About

Publications While At HealthPartners

selected publications

Journal Article

Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: patient-reported outcomes in ECOG-ACRIN EA1131. 

Cancer. 2024

Randomized phase III postoperative trial of platinum-based chemotherapy versus capecitabine in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: ECOG-ACRIN EA1131. 

Journal of Clinical Oncology. 2021

Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial. 

Cancer medicine. 2020

Randomized phase II trial of fulvestrant plus everolimus or placebo in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer resistant to aromatase inhibitor therapy: results of PrE0102. 

Journal of Clinical Oncology. 2018

Contact

full name

F. Zhao

Quick Info

 

Collaboration

Co-author network

Map of science